Immune Checkpoint-Related Gene Polymorphisms and High Serum Concentration of PD-L1 and CTLA4 Contribute to the Resistance to Platinum-Based Chemotherapy in Cervical Cancer
The <i>PDCD1</i>- rs2227982, <i>CD274</i>-rs2890658 and <i>CTLA4</i>- rs3087243 polymorphisms and high serum levels of PD-L1 and CTLA4 may predict chemotherapy resistance in cervical cancer patients.
Authors
- Hongqin Yuan
- Kaidong Liu
- Jia Zhang
- Pei Wang
- Xinfeng Wang
Institutions
- Shanxi Provincial Cancer Hospital (CN)
Publication Details
- Journal
- International Journal of Women s Health
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/ijwh.s569408
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00